Skip to content

Application of Z-shaped supine position in robot-assisted radical prostatectomy: a single-center randomized controlled trial study

Application of Z-shaped supine position in robot-assisted radical prostatectomy: a single-center randomized controlled trial study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072954
Enrollment
Unknown
Registered
2023-06-28
Start date
2023-11-24
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

Control group:The conventional Trendelenburg position was adopted.
experimental group:The Z-shaped supine position was adopted.

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Prostate cancer patients undergoing robot-assisted radical prostatectomy;

Exclusion criteria

Exclusion criteria: 1. History of ophthalmic surgery within the past 3 months; 2. Diagnosis of lower limb ischemic vascular diseases such as peripheral arterial disease and thromboangiitis obliterans; 3. Currently diagnosed with central/peripheral nerve disease or has had symptoms of lumbar disc herniation within the past year. 4. Patients undergoing repeat surgery for recurrent prostate cancer.

Design outcomes

Primary

MeasureTime frame
Postoperative incidence of nerve injury;

Secondary

MeasureTime frame
The incidence of intraocular hypertension during operation;High incidence of intraoperative calf muscle pressure;Incidence of postoperative deep vein thrombosis;pain score;The incidence of intraoperative skin pressure injury (pressure ulcer);Intraoperative condition;

Countries

China

Contacts

Public ContactYifang Hou

Peking University Shenzhen Hospital

ryf79@126.com+86 135 8070 8340

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026